Study Title and Description
A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.
Key Questions Addressed
|3||In adult renal transplants, how do immunosuppressive regimens designed to reduce or eliminate exposure to CNI toxicity compare with each other and with full-dose CNI regimens for health outcomes? AND How does the type of induction agent (including when no induction is used) and the use of concurrent immunosuppressive agents affect outcomes of regimens that reduce or eliminate CNI exposure?|
Primary Publication Information
|Title||A 50% reduction in cyclosporine exposure in stable renal transplant recipients: renal function benefits.|
|Author||Etienne I., Toupance O., Bénichou J., Thierry A., Al Najjar A., Hurault de Ligny B., Le Meur Y., Westeel PF., Marquet P., François A., Hellot MF., Godin M.|
|Country||Department of Nephrology, Rouen University Hospital, and Inserm CIC 0204, Institute of Biomedical Research, University of Rouen, Rouen, France. Isabelle.Etienne@chu-rouen.fr|
Pubmed ID: 20299336
Secondary Publication Information
There are currently no secondary publications defined for this study.
Extraction Form: Comparative Effectiveness of Regimens
Results & Comparisons
No Results found.